ARRY-424704, ARRY-704 Chemical Properties

Density 

1.732

storage temp. 

Store at -20°C

solubility 

≥23.05 mg/mL in DMSO; insoluble in H2O; ≥46.1 mg/mL in EtOH

form 

solid

pka

14.31±0.10(Predicted)

Safety Information

HS Code 

2933998090

ARRY-424704, ARRY-704 Usage And Synthesis

Description

AZD 8330 is a selective allosteric inhibitor of MEK1/2 (IC₅₀ = 7 nM). It blocks phosphorylation of ERK1/2 and inhibits proliferation of certain cancer cells. AZD 8330 is orally bioavailable, inhibits ERK phosphorylation in vivo, and reduces tumor growth in a Calu-6 nude rat xenograft model.

Uses

AZD8330 is an orally active and selective MEK inhibitor.

Definition

ChEBI: 2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-3-pyridinecarboxamide is a pyridinecarboxamide. It is functionally related to a nicotinamide.

target

ERK phosphorylation

References

1. feng k, wang c, zhou h, yang j, dong l, zhou k, et al. [effect of erk1/2 inhibitor azd8330 on human burkitt's lymphoma cell line raji cells and its mechanism]. zhonghua xue ye xue za zhi 2015,36:148-152.2. cohen rb, aamdal s, nyakas m, cavallin m, green d, learoyd m, et al. a phase i dose-finding, safety and tolerability study of azd8330 in patients with advanced malignancies. eur j cancer 2013,49:1521-1529.

ARRY-424704, ARRY-704(869357-68-6)Related Product Information

• Binimetinib
• BKM120 (NVP-BKM120, Buparlisib)
• MLN0905
• 2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid
• NVP-BVU 972
• Tozasertib
• R428
• Nutlin 3a
• 6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline
• 6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide
• BMS-794833
• AZD-4547
• 5-Aza-2'-deoxycytidine
• TAK-733
• PD 0325901
• CAL-101
• BEZ235 (NVP-BEZ235, Dactolisib)